Reverse Mergers and SPACs: Are APOs the New Norm for Biotechs Going Public?
Cybersecurity Best Practices for 2021
Pivot to Cash: Bankruptcy & Restructuring in a Distressed Environment
Microbiome: Hope or Hype?
M&A Outlook 2019
This webinar discussion is focused around best practices in due diligence, potential red flags to avoid, and how working with an experienced team of trusted advisors paired with the right tools can help accelerate the discovery process.
Maximizing M&A Value, Minimizing Risk: Business Process Integration - Part II
M&A Integration: Maximizing the Return on Technology and Talent
Do's and Don'ts of the M&A Process
Biotech and Pharma Licensing Negotiations
The Nuts & Bolts of Selecting a Contract Research Organization
This webinar evaluated how to determine internal champions/selection committees, strategic sourcing/procurement workflow/checklist, documentation and regulations, challenges of CRO outsourcing, and best practices to get best value.
M&A Negotiations: Are You As Good As You Could Be?
In this webinar, the most common scenarios that arise when you are selling your company, the choices you have when negotiating the terms of the sale, and which choices are your best ones, as supported by academic research are covered.
The Seven Deadly Sins of Selling Your Tech Company